Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.

Rayes N, Bowen DJ, Coffin T, Nebgen D, Peterson C, Munsell MF, Gavin K, Lechner R, Crase J, Polinsky D, Romero I, Blank SV, Levine DA, Norquist BM, Swisher EM, Lu KH.

BMC Cancer. 2019 Jul 2;19(1):648. doi: 10.1186/s12885-019-5868-x.

2.

The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.

Jalloul RJ, Nick AM, Munsell MF, Westin SN, Ramirez PT, Frumovitz M, Soliman PT.

J Gynecol Oncol. 2018 Sep;29(5):e68. doi: 10.3802/jgo.2018.29.e68. Epub 2018 May 4.

3.

Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.

Meyer LA, Lasala J, Iniesta MD, Nick AM, Munsell MF, Shi Q, Wang XS, Cain KE, Lu KH, Ramirez PT.

Obstet Gynecol. 2018 Aug;132(2):281-290. doi: 10.1097/AOG.0000000000002735.

4.

Nuclear ╬▓-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.

Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus R.

Mod Pathol. 2018 Oct;31(10):1553-1559. doi: 10.1038/s41379-018-0080-0. Epub 2018 May 24.

5.

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.

Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH.

Gynecol Oncol. 2018 Jul;150(1):79-84. doi: 10.1016/j.ygyno.2018.04.564. Epub 2018 May 4.

PMID:
29735278
6.

Setting Benchmarks for the New User: Training on the Robotic Simulator.

Dioun SM, Fleming ND, Munsell MF, Lee J, Ramirez PT, Soliman PT.

JSLS. 2017 Oct-Dec;21(4). pii: e2017.00059. doi: 10.4293/JSLS.2017.00059.

7.

Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer.

Fleming ND, Coleman RL, Tung C, Westin SN, Hu W, Sun Y, Bhosale P, Munsell MF, Sood AK.

Gynecol Oncol. 2017 Oct;147(1):41-46. doi: 10.1016/j.ygyno.2017.07.137. Epub 2017 Aug 1.

8.

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.

Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH.

Gynecol Oncol. 2017 Aug;146(2):399-404. doi: 10.1016/j.ygyno.2017.05.037. Epub 2017 Jun 10.

9.

A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.

Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KH.

Gynecol Oncol. 2017 Aug;146(2):234-239. doi: 10.1016/j.ygyno.2017.05.016. Epub 2017 May 18.

10.

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN.

Gynecol Oncol. 2017 Jul;146(1):27-33. doi: 10.1016/j.ygyno.2017.04.018. Epub 2017 Apr 30.

11.

Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.

Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, Frumovitz M.

Gynecol Oncol. 2017 Apr;145(1):96-101. doi: 10.1016/j.ygyno.2017.02.005. Epub 2017 Feb 8.

12.

Paget's disease of the vulva: A review of 89 cases.

Onaiwu CO, Salcedo MP, Pessini SA, Munsell MF, Euscher EE, Reed KE, Schmeler KM.

Gynecol Oncol Rep. 2016 Dec 30;19:46-49. doi: 10.1016/j.gore.2016.12.010. eCollection 2017 Feb.

13.

Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.

Frumovitz M, Munsell MF, Burzawa JK, Byers LA, Ramalingam P, Brown J, Coleman RL.

Gynecol Oncol. 2017 Jan;144(1):46-50. doi: 10.1016/j.ygyno.2016.10.040. Epub 2016 Nov 4.

14.

Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.

Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):793-800. doi: 10.1016/j.ijrobp.2016.07.035. Epub 2016 Jul 30.

15.

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Soliman PT, Zhang Q, Broaddus RR, Westin SN, Iglesias D, Munsell MF, Schmandt R, Yates M, Ramondetta L, Lu KH.

Gynecol Oncol. 2016 Dec;143(3):466-471. doi: 10.1016/j.ygyno.2016.10.011. Epub 2016 Oct 13.

16.

Ewing sarcoma family of tumors in children younger than 10 years of age.

Huh WW, Daw NC, Herzog CE, Munsell MF, McAleer MF, Lewis VO.

Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26275. Epub 2016 Oct 3.

PMID:
27696711
17.

The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology.

Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM.

Ann Surg Oncol. 2017 Feb;24(2):362-368. doi: 10.1245/s10434-016-5517-4. Epub 2016 Aug 29.

18.

Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer.

Nebgen DR, Rhodes HE, Hartman C, Munsell MF, Lu KH.

Obstet Gynecol. 2016 Aug;128(2):357-63. doi: 10.1097/AOG.0000000000001529.

19.

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.

Chadha AS, Skinner HD, Gunther JR, Munsell MF, Das P, Minsky BD, Delclos ME, Chatterjee D, Wang H, Clemons M, George G, Singh PK, Katz MH, Fleming JB, Javle MM, Wolff RA, Varadhachary GR, Crane CH, Krishnan S.

PLoS One. 2016 Jun 23;11(6):e0156910. doi: 10.1371/journal.pone.0156910. eCollection 2016.

20.

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology.

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Cancer Treat Rev. 2016 May;46:1-8. doi: 10.1016/j.ctrv.2016.03.010. Epub 2016 Mar 28. Review.

21.

Carcinoma of the Bartholin Gland: A Review of 33 Cases.

Bhalwal AB, Nick AM, Dos Reis R, Chen CL, Munsell MF, Ramalingam P, Salcedo MP, Ramirez PT, Sood AK, Schmeler KM.

Int J Gynecol Cancer. 2016 May;26(4):785-9. doi: 10.1097/IGC.0000000000000656.

22.

Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study.

Siefker-Radtke AO, Campbell MT, Munsell MF, Harris DR, Carolla RL, Pagliaro LC.

Urology. 2016 Mar;89:83-9. doi: 10.1016/j.urology.2015.12.007. Epub 2015 Dec 23.

23.

Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.

Callegaro-Filho D, Gershenson DM, Nick AM, Munsell MF, Ramirez PT, Eifel PJ, Euscher ED, Marques RM, Nicolau SM, Schmeler KM.

Gynecol Oncol. 2016 Jan;140(1):53-7. doi: 10.1016/j.ygyno.2015.11.004. Epub 2015 Nov 4.

24.

Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer.

Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM.

Gynecol Oncol. 2015 Dec;139(3):553-8. doi: 10.1016/j.ygyno.2015.09.079. Epub 2015 Sep 30.

PMID:
26432043
25.

Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.

dos Reis R, Burzawa JK, Tsunoda AT, Hosaka M, Frumovitz M, Westin SN, Munsell MF, Ramirez PT.

Int J Gynecol Cancer. 2015 Sep;25(7):1292-9. doi: 10.1097/IGC.0000000000000490.

26.

Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs.

Ring KL, Ramirez PT, Conrad LB, Burke W, Wendel Naumann R, Munsell MF, Frumovitz M.

Int J Gynecol Cancer. 2015 Jul;25(6):1115-20. doi: 10.1097/IGC.0000000000000466.

27.

A Comparison Between Appendiceal and Nonappendiceal Neuroendocrine Tumors in Children and Young Adults: A Single-institution Experience.

Boston CH, Phan A, Munsell MF, Herzog CE, Huh WW.

J Pediatr Hematol Oncol. 2015 Aug;37(6):438-42. doi: 10.1097/MPH.0000000000000350.

PMID:
25985239
28.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, van den Borne BE, Munsell MF, Hurkmans C, Berry DA, van Werkhoven E, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJ, Carpenter LS, De Jaeger K, Komaki R, Slotman BJ, Smit EF, Roth JA.

Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13. Erratum in: Lancet Oncol. 2015 Sep;16(9):e427.

29.

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology.

Conrad LB, Ramirez PT, Burke W, Naumann RW, Ring KL, Munsell MF, Frumovitz M.

Int J Gynecol Cancer. 2015 Jul;25(6):1121-7. doi: 10.1097/IGC.0000000000000450.

30.

Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.

Simmons PJ, Robinson SN, Munsell MF, Thomas MW, Javni JA, Brouard N, Zweidler-McKay PA, Shpall EJ.

Stem Cells Dev. 2015 May 1;24(9):1066-72. doi: 10.1089/scd.2014.0439. Epub 2015 Mar 18.

31.

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.

Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA.

Springerplus. 2015 Jan 30;4:36. doi: 10.1186/s40064-015-0840-y. eCollection 2015.

32.

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL.

J Clin Oncol. 2015 Mar 10;33(8):930-6. doi: 10.1200/JCO.2014.58.3401. Epub 2015 Jan 26.

33.

Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.

Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, Pan HY, Chang JY, Komaki R, Cox JD, McAleer MF, Grosshans DR.

J Thorac Oncol. 2014 Oct;9(10):1554-60. doi: 10.1097/JTO.0000000000000306.

34.

Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.

Fleming ND, Frumovitz M, Schmeler KM, dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT.

Gynecol Oncol. 2015 Jan;136(1):48-53. doi: 10.1016/j.ygyno.2014.11.010. Epub 2014 Nov 18.

35.

Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database.

Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DC.

Gynecol Oncol. 2015 Jan;136(1):65-70. doi: 10.1016/j.ygyno.2014.11.009. Epub 2014 Nov 14.

36.

Position-related injury is uncommon in robotic gynecologic surgery.

Ulm MA, Fleming ND, Rallapali V, Munsell MF, Ramirez PT, Westin SN, Nick AM, Schmeler KM, Soliman PT.

Gynecol Oncol. 2014 Dec;135(3):534-8. doi: 10.1016/j.ygyno.2014.10.016. Epub 2014 Oct 23.

37.

Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.

Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, Schmeler KM, Klopp AH, Fleming ND.

Gynecol Oncol. 2014 Dec;135(3):455-61. doi: 10.1016/j.ygyno.2014.10.022. Epub 2014 Oct 28.

38.

Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.

Prescott LS, Kidin LM, Downs RL, Cleveland DJ, Wilson GL, Munsell MF, DeJesus AY, Cain KE, Ramirez PT, Kroll MH, Levenback CF, Schmeler KM.

Int J Gynecol Cancer. 2015 Jan;25(1):152-9. doi: 10.1097/IGC.0000000000000312.

39.

Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.

McGovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, McAleer MF, Chintagumpala M, Khatua S, Mahajan A.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1143-52. doi: 10.1016/j.ijrobp.2014.08.354. Epub 2014 Oct 11.

40.

Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy.

Dickstein RJ, Munsell MF, Pagliaro LC, Pettaway CA.

BJU Int. 2016 Jan;117(1):118-25. doi: 10.1111/bju.12946. Epub 2015 Jun 3.

41.

Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.

Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ.

Brachytherapy. 2015 Mar-Apr;14(2):160-5. doi: 10.1016/j.brachy.2014.08.045. Epub 2014 Sep 23.

42.

Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome.

Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM.

Gynecol Oncol. 2014 Oct;135(1):85-9. doi: 10.1016/j.ygyno.2014.08.017. Epub 2014 Aug 19.

43.

Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes?

Slaughter KN, Frumovitz M, Schmeler KM, Nick AM, Fleming ND, dos Reis R, Munsell MF, Westin SN, Soliman PT, Ramirez PT.

Gynecol Oncol. 2014 Aug;134(2):248-52. doi: 10.1016/j.ygyno.2014.06.007. Epub 2014 Jun 16.

44.

Conversion from robotic surgery to laparotomy: a case-control study evaluating risk factors for conversion.

Jones N, Fleming ND, Nick AM, Munsell MF, Rallapalli V, Westin SN, Meyer LA, Schmeler KM, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Aug;134(2):238-42. doi: 10.1016/j.ygyno.2014.06.008. Epub 2014 Jun 14.

45.

Physician pain and discomfort during minimally invasive gynecologic cancer surgery.

McDonald ME, Ramirez PT, Munsell MF, Greer M, Burke WM, Naumann WT, Frumovitz M.

Gynecol Oncol. 2014 Aug;134(2):243-7. doi: 10.1016/j.ygyno.2014.05.019. Epub 2014 Jun 2.

46.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.

J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.

47.

Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.

Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):846-53. doi: 10.1016/j.ijrobp.2014.04.019. Epub 2014 May 24.

48.

Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation.

Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV.

Ann Surg Oncol. 2014 Aug;21(8):2512-6. doi: 10.1245/s10434-014-3528-6. Epub 2014 Apr 16.

PMID:
24736987
49.

Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer.

Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ.

Pract Radiat Oncol. 2013 Apr-Jun;3(2):115-23. doi: 10.1016/j.prro.2012.03.014. Epub 2012 May 11.

PMID:
24674314
50.

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

Meyer LA, Slomovitz BM, Djordjevic B, Westin SN, Iglesias DA, Munsell MF, Jiang Y, Schmandt R, Broaddus RR, Coleman RL, Galbincea JM, Lu KH.

Int J Gynecol Cancer. 2014 May;24(4):713-7. doi: 10.1097/IGC.0000000000000118.

Supplemental Content

Loading ...
Support Center